rs17096918
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004621.6(TRPC6):c.170+70G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.1 in 1,515,402 control chromosomes in the GnomAD database, including 12,126 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_004621.6 intron
Scores
Clinical Significance
Conservation
Publications
- focal segmental glomerulosclerosis 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0936 AC: 14234AN: 152066Hom.: 1289 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.101 AC: 137218AN: 1363218Hom.: 10829 Cov.: 31 AF XY: 0.104 AC XY: 69655AN XY: 669208 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0937 AC: 14253AN: 152184Hom.: 1297 Cov.: 32 AF XY: 0.102 AC XY: 7603AN XY: 74384 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
not specified Benign:1
This variant is classified as Benign based on local population frequency. This variant was detected in 25% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 23. Only high quality variants are reported. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at